An ultra-performance liquid chromatography-tandem mass spectrometry method has been developed and validated for the determination of ethylglucuronide (EtG) in oral fluid. Sample clean-up was achieved by solid-phase extraction with a Hyper-SEP SAX column. Negative ionization was performed in the multiple reaction monitoring mode. Two transitions were monitored for the analyte and one for the internal standard EtG-d 5 . The calibration range was 4.4-222 ng/mL. The recovery of the analyte ranged from 86 to 99%, and the between-assay precisions ranged from 5 to 9% RSD. The limit of quantification was found to be 4.4 ng/mL. The concentration of EtG in oral fluid collected 2-14 h after a moderate alcohol intake varied from 13.3 to 57.7 ng/mL.
Introduction
After alcohol intake ethanol can be detected in a series of different biological samples for a time period reflecting ethanol's presence in blood. Ethanol is mainly oxidized to acetaldehyde in the liver, and only a small fraction of ethanol becomes conjugated to ethylglucuronide (EtG) by UDP-glucuronosyl transferase (1) . Although the formation of EtG represents only < 1% of the total alcohol elimination, EtG has shown to be a specific marker of ethanol intake in blood and urine (2) (3) (4) (5) . EtG could be detected in blood for 10-14 h and in urine for 25-35 h after a single moderate intake of alcohol and accordingly it was present for several hours in both media after ethanol had disappeared (5) . EtG is a marker of recent alcohol intake, which may be relevant in, for example, workplace testing and as a relapse marker in clinical settings. For such purposes urine samples have previously been used (6) . However, less invasive sampling procedures like oral fluid collection should be considered as a substitute. Several liquid chromatography-tandem mass spectrometry (LC-MS-MS) methods for determination of illicit and medicinal drugs in oral fluid have been previously reported (7-12); however, EtG was not included in these studies. The aim of the present study was to develop a robust and specific ultra-performance liquid chromatography (UPLC)-MS-MS method for the quantification of EtG in oral fluid. As far as we know, this is the first validated method of EtG in oral fluid.
Material and Methods

Chemicals and reagents
EtG and EtG-d 5 were obtained from Medichem (Steinenbronn, Germany). Other chemicals were of high-performance liquid chromatography or analytical grade from various commercial sources. The Hyper-SEP SAX (200 mg, 3 mL) extraction columns were purchased from Thermo Scientific (Bellefonte, PA). Saliva Sampler collection devices, filter sampler, and preservative buffer were obtained from Saliva Diagnostic Systems (Medford, NY). The devices contained a buffer with sodium azide (0.2%) as a preservative.
Preparation of solutions
Two separate stock solutions were prepared to a concentration of 2.2 mg/mL in methanol and were used for calibrator and quality control (QC) samples. Aqueous calibration solutions with the concentration of 17.8, 44.4, 88.8, 222, 444, and 888 ng/mL were prepared from the stock solution. Aqueous QC solutions were prepared from the stock solution to the concentration of 35.5, 133.2, and 355.2 ng/mL. The internal standard EtG-d 5 was diluted with water to a concentration of 227.0 ng/mL. The stock and aqueous solutions were stored at -20°C and 4°C, respectively. The saliva sampler set contained 1.0 mL of preservative buffer, and the expected volume of oral fluid was 1.0 mL, giving a 1+1 dilution that was compensated for in the preparation of calibrators and QCs samples. Subsequently, the calibration and QC samples were made by adding 50 µL of aqueous calibration and QC solution to 200 µL preservative buffer/water (1:1, v/v).
Determination of Ethylglucuronide in Oral Fluid by Ultra-Performance Liquid ChromatographyTandem Mass Spectrometry Sample collection
Blank oral fluid samples were obtained from laboratory personnel through verbal consent.
Alcohol-positive oral fluid samples were collected from three subjects in a private party with moderate alcohol (0.5-1 L of wine) consumption. The samples were collected before alcohol intake and after 2, 3, 5, and 14 h after start of drinking. There was no alcohol intake after 1.5 h. The oral fluid was collected according to the instructions from Saliva Diagnostic System (http://www.salv.com/). The saliva collection devices consisted of a collector (with blue volume indicator) and transport tube. The pad was able to collect~1 mL of oral fluid, and the transport tube contained 1 mL preservative buffer. The amount of collected oral fluid was determined by weighing the collection devices. The weight of the oral fluid devices before sampling used was an average of 10 different devices (RSD 0.5%). The weight was used for correction when calculating the concentration of EtG. The extracts were stored at -20°C to ensure that EtG and ethanol remained stable until analysis.
Sample treatment
To 200 µL oral fluid/preservative buffer mixture, 50 µL EtG-d 5 and 1 mL water were added. The mixed sample was applied to a Hyper-SEP SAX column preconditioned with methanol (2 mL) and water (2 mL). The column was washed with water (2 mL) and methanol (2 mL). The analyte was eluted with 2 mL methanol/formic acid (98:2, v/v). The eluate was evaporated to dryness under N 2 (50°C), dissolved in 60 µL water, and put into the freezer (-20°C) for 30 min. The sample was thawed and centrifuged (5251 × g, 15 min 4°C), and the clear phase was transferred to autosampler vials.
Instrumentation
UPLC. UPLC was performed using a Waters Acquity system (Manchester, U.K.). Separation was performed on a Waters HSS T3 (2.1 × 100 mm, 1.8 µm) column, using gradient elution at a flow rate of 0.4 mL/min with the following binary solvent system: 0.1% formic acid in water (A) and 100% methanol (B). The gradient was run as follows: 0 min, A 99 %, B 1%; 2.0 min, A 80%, B 20%; 2.2 min A 10%, B 90%; 2.21 min, A 99%, B 1%. The total runtime for the method was 3.0 min. The column temperature was held at 65°C during analysis. The injection volume was 7.5 µL performed by partial loop injection using needle overfill as the injection technique. A dual wash was applied to the autosampler using 600 µL methanol/water (10:90, v/v) and 200 µL methanol/water (90:10, v/v), denoted as weak and strong wash.
MS-MS.
A Quattro Premier XE tandem-quadrupole MS (Waters) equipped with a Z-spray electrospray interface was used. Negative ionization was performed in the multiple reaction monitoring (MRM) mode. The capillary voltage was set to 1.0 kV, the source block temperature was 120°C, and the desolvation gas (nitrogen) was heated to 400°C and delivered at a flow rate of 1000 L/h. The cone gas (nitrogen) was set to 50 L/h and the collision gas (argon) pressure was maintained at 0. System operation and data acquisition were controlled using Mass Lynx 4.1 software (Waters). All data were processed with the QuanLynx quantification program (Waters). The analyte was identified by comparing the retention time of the corresponding calibrator and QC samples. The ratio between the two MRM transitions was also compared with those of the corresponding calibrator and QC samples and should not deviate more than 20%.
Method validation
The six-point calibration curves were based on peak-height ratios of the analyte relative to the internal standard using a weighted (1/x) linear line, which included the origin. Withinassay precision was estimated by analysis of 10 separate replicates of QC samples at three concentration in a single assay (n = 10). Between-assay precision and accuracy were determined by analysis of aliquots of each QC concentration at 10 different days, one replicate in each assay. The recovery was determined with six replicates at each QC concentration. Recovery was estimated by comparing peak heights obtained when the analyte was added before sample preparation with those obtained when the analyte was added after the extraction step. In both cases the internal standard was added after the extraction step.
Matrix effects (ME) were evaluated by the method proposed by Matuszewski et al. (13) . The analyte signal in the spiked water was compared with the analyte signal in the matrix fortified after extraction, and the ME was defined as ME% = (extracted matrix height/water height) × 100. Five replicates of oral fluid (from five different individuals) extracts were analyzed. The concentrations corresponded to the lowest and highest QC sample. The limit of quantification (LOQ) was determined at the lowest calibrator sample. The sample was run in one replicate on 10 different days, and signal to noise was evaluated. The signal to noise criteria for both transitions were > 10. In order to investigate the specificity of the method, selected prescription (1-300 µg/mL) drugs, which are ionized in the negative ESI mode, were injected into the UPLC-MS-MS system. The drugs (n = 52) tested were antiepileptics, cardiovascular drugs, barbiturates, NSAIDs, and GHB. Alcohol was analyzed by an automated enzymatic method using alcohol dehydrogenase (14) .
Results and Discussion
Method validation
The MRM chromatograms of the EtG and EtG-d 5 from the lowest calibrator are shown in Figure 1 . The calibration range, LOQ, within-assay precision, between-assay precision, bias, and recovery for EtG are presented in Table I . The withinassay RSDs were 4.1%-8.4%, and the between-assay RSDs were 5.0%-9.3%. The bias was in the range -6.7 to 7.5%, and recoveries ranged from 86 to 99%. The observed matrix effects indicate some ion enhancement (Table II) ; however, the observed values were considered acceptable. None of the compounds investigated in the specificity experiments interfered in the MRM chromatograms. Another alcohol metabolite, ethylsulfate, which has previously been detected in blood and urine (15) (16) (17) (18) , was not included in this method because of its unsuitability (recovery 0%) for the extraction procedure used in this method. The extraction method presented was necessary for EtG to obtain the required sensitivity.
Application
All oral fluid samples collected before start of drinking were found to be negative for EtG and ethanol. The concentrations of EtG and ethanol are shown in Table III . The concentration of EtG in samples taken the morning after the alcohol consumption (14 h) were between 20.0 and 57.7 ng/mL, whereas ethanol was negative in all samples. This was in accordance with the oral fluid ethanol concentrations measure at 5 h, which indicate that all ethanol would have disappeared from blood and oral fluid at least at 9 h for all three subjects. Thus EtG could be detected in oral fluid for several hours after ethanol concentration had return to zero. Chromatograms from a real sample are shown in Figure 2 .
Conclusions
A specific and robust method for quantification of EtG in oral fluid by UPLC-MS-MS has been developed. It has been validated with satisfactory results in regards to separation, sensitivity, recovery, linearity, and specificity. EtG has been detected in oral fluid, 14 h after a moderate intake of alcohol, when ethanol was no longer present. EtG in oral fluid is thus a potential marker of recent alcohol intake, extending the alcohol time detection window possibly with several hours. Further controlled studies should be performed for evaluating the pharmacokinetics of EtG in blood and oral fluid, and its role as a possible potential biomarker of recent alcohol intake in clinical and workplace settings.
